Rate and association of lower urinary tract infection with recurrence after transurethral resection of bladder tumor
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Byung Soo | - |
dc.contributor.author | Tae, Bum Sik | - |
dc.contributor.author | Ku, Ja Hyeon | - |
dc.contributor.author | Kwak, Cheol | - |
dc.contributor.author | Kim, Hyeon Hoe | - |
dc.contributor.author | Jeong, Chang Wook | - |
dc.date.accessioned | 2021-09-02T17:00:07Z | - |
dc.date.available | 2021-09-02T17:00:07Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2018-01 | - |
dc.identifier.issn | 2466-0493 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/78426 | - |
dc.description.abstract | Purpose: To evaluate the rate of pyuria and bacteriuria after transurethral resection of bladder tumor (TURBT). Materials and Methods: We retrospectively evaluated data obtained from 363 patients who underwent TURBT between October 2012 and December 2013 at Seoul National University Hospital. Urinalysis and urine culture were assessed at 3, 6, 12, and 24 months postoperatively. Primary endpoint was the rate of bacteriuria (>= 105/mL in a midstream) and pyuria (white blood cells >= 5/high- power field). Results: We analyzed 306 patients who were eligible for the study. Pyuria was present in 23.5% of patients in the 3rd postoperative month and in 31.7% of patients in the 24th postoperative month. Bacteriuria was present in 1.3% of patients in the 3rd postoperative month and in 2.6% of patients in the 24th postoperative month. Among urothelial carcinoma patients (n=220), 24.1% showed pyuria and 1.8% showed bacteriuria at the 3rd postoperative month. We found that 31.8% showed pyuria and 3.2% showed bacteriuria at the 24th postoperative month. There was no significant difference in the rate of pyuria and bacteriuria between the intravesical treatment group and the no-treatment group. Multivariate analysis demonstrated that pyuria in the 3rd postoperative month (odd ratio [ OR], 2.254; p=0.039), tumor multiplicity (OR, 3.331; p=0.001), and the absence of intravesical treatment (OR, 4.927; p=0.001) increases the risk of tumor recurrence. Conclusions: A significant proportion of patients showed pyuria after TURBT during the follow-up period. Additionally, presence of pyuria in the short-term follow-up period after TURBT constitutes a risk factor for recurrence of bladder cancer. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN UROLOGICAL ASSOC | - |
dc.subject | RANDOMIZED CLINICAL-TRIAL | - |
dc.subject | ASYMPTOMATIC BACTERIURIA | - |
dc.subject | UROTHELIAL CARCINOMA | - |
dc.subject | CANCER | - |
dc.subject | PROPHYLAXIS | - |
dc.subject | MANAGEMENT | - |
dc.subject | SURVIVAL | - |
dc.subject | DISEASE | - |
dc.subject | UPDATE | - |
dc.subject | PYURIA | - |
dc.title | Rate and association of lower urinary tract infection with recurrence after transurethral resection of bladder tumor | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Tae, Bum Sik | - |
dc.identifier.doi | 10.4111/icu.2018.59.1.10 | - |
dc.identifier.scopusid | 2-s2.0-85040029180 | - |
dc.identifier.wosid | 000423168400003 | - |
dc.identifier.bibliographicCitation | INVESTIGATIVE AND CLINICAL UROLOGY, v.59, no.1, pp.10 - 17 | - |
dc.relation.isPartOf | INVESTIGATIVE AND CLINICAL UROLOGY | - |
dc.citation.title | INVESTIGATIVE AND CLINICAL UROLOGY | - |
dc.citation.volume | 59 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 10 | - |
dc.citation.endPage | 17 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002308121 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Urology & Nephrology | - |
dc.relation.journalWebOfScienceCategory | Urology & Nephrology | - |
dc.subject.keywordPlus | RANDOMIZED CLINICAL-TRIAL | - |
dc.subject.keywordPlus | ASYMPTOMATIC BACTERIURIA | - |
dc.subject.keywordPlus | UROTHELIAL CARCINOMA | - |
dc.subject.keywordPlus | CANCER | - |
dc.subject.keywordPlus | PROPHYLAXIS | - |
dc.subject.keywordPlus | MANAGEMENT | - |
dc.subject.keywordPlus | SURVIVAL | - |
dc.subject.keywordPlus | DISEASE | - |
dc.subject.keywordPlus | UPDATE | - |
dc.subject.keywordPlus | PYURIA | - |
dc.subject.keywordAuthor | Pyuria | - |
dc.subject.keywordAuthor | Recurrence | - |
dc.subject.keywordAuthor | Urinary bladder neoplasms | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.